Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Molecular Neurodegeneration|August 4, 2023
VPS35 and α-Synuclein fail to interact to modulate neurodegeneration in rodent models of Parkinson's diseaseXi Chen, Elpida Tsika, Nathan Levine, et al.NPJ Parkinson'S Disease|July 19, 2024
Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalitiesMadalynn L Erb, Kayla Sipple, Nathan Levine, et al.Acta Neuropathologica Communications|March 16, 2019
Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respirationXinhe Wang, Katelyn Becker, Nathan Levine, et al.Proceedings of the National Academy of Sciences of the United States of America|July 8, 2020
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activityAn Phu Tran Nguyen, Elpida Tsika, Kaela Kelly, et al.Proceedings of the National Academy of Sciences of the United States of America|March 8, 2019
Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegenerationXi Chen, Jennifer K Kordich, Erin T Williams, et al.Biorxiv : the Preprint Server for Biology|December 11, 2025
Targeting Metabolic Dysfunction and Inflammation with Sotagliflozin Reverses Diastolic Dysfunction in Experimental HFpEFParisa Shabani, Tahra Luther, Rajesh Chaudhary, et al.Neurobiology of Disease|July 6, 2019
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrilsJoseph R Patterson, Megan F Duffy, Christopher J Kemp, et al.Pageof 1